Twist Bioscience Corp at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 11:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Good afternoon, everyone. Thank you for joining us. My name is Matt Sykes, life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming the management team from Twist Bioscience today, Emily Leproust, the CEO and Co-Founder; and Jim Thorburn, the CFO. Emily, Jim, thank you very much for joining us today.

Emily Marine Leproust - Twist Bioscience Corporation - Co-Founder, Chairman & CEO

Thank you.

Questions and Answers:

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe I think it would be helpful to maybe for you to set the stage first, talk about the most recent results and kind of what sort of trends you're seeing for the business over the course of the second half of this year.

James M. Thorburn - Twist Bioscience Corporation - CFO & Principal Accounting Officer

Yes. So in terms of recent
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot